Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Gemcitabine
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 200 mg
- Dosage form
- Powder for injection
- Pack
- 1's
- Registration no.
- 095876
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 3,607.31 to 3,785.51 (+4.9%) between 25 Aug 2025 and 20 Aug 2026 · 2 official price records · pack 1's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. ZEFEI 200 mg, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/zefei-200-mg-095876-1s-aa-pharma/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 3,785.51 | 2026-08-20 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 3,607.31 | 2025-08-25 | 2026-08-07 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 095876Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
